Leerink Partners Starts Janux Therapeutics (JANX) at Outperform
Tweet Send to a Friend
(Updated - November 22, 2024 6:28 AM EST)
Leerink Partners analyst Jeffrey La Rosa initiates coverage on Janux Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Jeffrey La Rosa initiates coverage on Janux Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
